Ovarian Cancer Clinical Trials

Showing 841-860 of 1,019 trials

Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With Stage IIB, Stage III, or Stage IV Ovarian Epithelial Cancer

NCT00006454

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known if paclitaxel plus carboplatin is more effective with or without topotecan for ovarian epithelial cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of paclitaxel plus carboplatin with or without topotecan in treating patients who have stage IIB, stage III, or stage IV ovarian epithelial cancer.

Fallopian Tube CancerOvarian Cancer

AGO Study GroupStarted Dec 1999

Berlin, Germany • Bonn, Germany • Bremen, Germany +16 more locations

WITHDRAWNPhase 1/2

BNC105P Combination Study in Partially Platinum Sensitive Ovarian Cancer Patients

NCT01624493

This phase I/II trial will determine the recommended dose and activity of BNC105P for patients with partially platinum sensitive ovarian cancer in first or second relapse.

Ovarian Cancer

Hoosier Cancer Research NetworkStarted Oct 2012

Chicago, Illinois, United States • Indianapolis, Indiana, United States • Sydney, New South Wales, Australia +3 more locations

Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With Stage IIB, Stage III, or Stage IV Ovarian Epithelial Cancer

BNC105P Combination Study in Partially Platinum Sensitive Ovarian Cancer Patients

Related Searches

Study of Ombrabulin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer Treated With Carboplatin/Paclitaxel

EMD 525797 in Colorectal and Ovarian Cancer Patients With Liver Metastases

Collection of Tissue Samples From Patients With Stage III or Stage IV Ovarian Epithelial Cancer

Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors

Sexual Functioning After Primary Treatment of Ovarian Cancer

Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors

Irinotecan and Bevacizumab for Recurrent Ovarian Cancer

Palliative Care During Intraperitoneal Chemotherapy in Patients With Ovarian Cancer

Elizabeth Registry for Low Grade Ovarian Cancer

An RCT of Concurrent and Maintenance Cediranib in Women With Platinum-sensitive Relapsed Ovarian Cancer

Panitumumab and Gemcitabine in Relapsed Ovarian Cancer

Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer

A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse Treatment

Vitamin D for Women at Increased Risk of Developing Ovarian, Fallopian, or Primary Peritoneal Cancer

UCN-01 and Topotecan in Treating Patients With Recurrent, Persistent, or Progressive Advanced Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

Tai-chi / Qi-gong in Patients With Patients With Gynecological Malignancies

Veliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BRCA Status

Strength Training Study for Survivors of Breast and Gynecologic Cancer